
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The stock probably has some legs. The Type 1 diabetes treatment they are working on is getting lots of attention. Trials continue to show results and they have raised money and signed agreements with large companies. It is a new biotech play and the potential market is very large. Unlock Premium - Try 5i Free
Sernova Biotherapeutics Inc is a OTC stock, trading under the symbol SVA.TO (previously SVA-T on Stockchase) on the (). It is usually referred to as or SVA.TO
In the last year, there was no coverage of Sernova Biotherapeutics Inc published on Stockchase.
Sernova Biotherapeutics Inc was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Sernova Biotherapeutics Inc .
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Sernova Biotherapeutics Inc in the last year. It is a trending stock that is worth watching.